GILD vs MGM · P/E 18, rev $7.80B vs P/E 64, rev $4.45B
Gilead Sciences Inc (GILD) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the GILD and MGM stock pages for the full models.
Not investment advice.